Nature research paper: Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
and is provided in this format here as a response to the exceptional public-health crisis. This accepted manuscript will continue through the processes of copy editing and formatting to publication of a finalized version of record on nature.com. Please note there may be errors present in this version, which may affect the content, and all legal disclaimers apply.
The severe acute respiratory syndrome coronavirus 2 epidemic in southern Africa has been characterised by three distinct waves. The first was associated with a mix of SARS-CoV-2 lineages, whilst the second and third waves were driven by the Beta and Delta variants, respectively. In November 2021, genomic surveillance teams in South Africa and Botswana detected a new SARS-CoV-2 variant associated with a rapid resurgence of infections in Gauteng Province, South Africa.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern AfricaNature research paper: Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
Read more »
Activity of convalescent and vaccine serum against SARS-CoV-2 OmicronA Nature research paper reports reduced effectiveness of vaccine- or infection-elicited antibodies against the SARS-CoV-2 Omicon variant, relative to other viral lineages
Read more »
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern AfricaNature research paper: Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
Read more »
Cypriot Researchers Reports New SARS-CoV-2 Variant, a Mix of Delta and OmicronA research team at the University of Cyprus has identified a new COVID-19 variant in 25 cases where the virus has signatures of both the Delta as well as the Omicron variants.
Read more »
Activity of convalescent and vaccine serum against SARS-CoV-2 OmicronA Nature research paper reports reduced effectiveness of vaccine- or infection-elicited antibodies against the SARS-CoV-2 Omicon variant, relative to other viral lineages
Read more »